Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAZNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XATNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used